Equillium, Inc.

Healthcare

NASDAQ:EQ · NASDAQ Global Market

Market Cap $108.34M Beta 1.76 P/E (TTM) -15.3

$3.05 +1.51%

+$0.05 today

52W Low $0.27High $3.45

Vol 0.42M · Avg 0.60M

EPS (TTM) -$0.20Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+951.72%

Period High

$3.17

Period Low

$0.29

Latest

$3.05

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Century Therapeutics, Inc.

NASDAQ:IPSC

$196.08M

Fortress Biotech, Inc.

NASDAQ:FBIO

$100.16M

OS Therapies Incorporated

AMEX:OSTX

$80.61M

Cue Biopharma, Inc.

NASDAQ:CUE

$71.79M

Spruce Biosciences, Inc.

NASDAQ:SPRB

$70.14M

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

$69.75M

Outlook Therapeutics, Inc.

NASDAQ:OTLK

$62.92M

Coeptis Therapeutics, Inc.

NASDAQ:COEP

$55.98M

Telomir Pharmaceuticals, Inc. Common Stock

TELO

$46.07M

Medicus Pharma Ltd. Common Stock

MDCX

$9.64M

What is the latest EQ filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does EQ have?

Intrinsic Alpha currently shows 20 recent filings for EQ.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.